US Bancorp’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $231 | Buy |
+60
| New | +$219 | ﹤0.01% | 4103 |
|
|
2025
Q4 | – | Sell |
-200
| Closed | -$1.4K | – | 4142 |
|
|
2025
Q3 | $1.4K | Sell |
200
-1,090
| -84% | -$7.58K | ﹤0.01% | 3794 |
|
|
2025
Q2 | $7.88K | Hold |
1,290
| – | – | ﹤0.01% | 3495 |
|
|
2025
Q1 | $9.8K | Sell |
1,290
-150
| -10% | -$1.25K | ﹤0.01% | 3439 |
|
|
2024
Q4 | $13.9K | Buy |
1,440
+1,240
| +620% | +$9.66K | ﹤0.01% | 3293 |
|
|
2024
Q3 | $1.18K | Hold |
200
| – | – | ﹤0.01% | 3872 |
|
|
2024
Q2 | $1.39K | Hold |
200
| – | – | ﹤0.01% | 3770 |
|
|
2024
Q1 | $1.54K | Hold |
200
| – | – | ﹤0.01% | 3770 |
|
|
2023
Q4 | $1.75K | Hold |
200
| – | – | ﹤0.01% | 3725 |
|
|
2023
Q3 | $1.46K | Hold |
200
| – | – | ﹤0.01% | 3711 |
|
|
2023
Q2 | $1.32K | Hold |
200
| – | – | ﹤0.01% | 3772 |
|
|
2023
Q1 | $682 | Hold |
200
| – | – | ﹤0.01% | 3919 |
|
|
2022
Q4 | $556 | Sell |
200
-251
| -56% | -$750 | ﹤0.01% | 3992 |
|
|
2022
Q3 | $1K | Hold |
451
| – | – | ﹤0.01% | 3976 |
|
|
2022
Q2 | $2K | Hold |
451
| – | – | ﹤0.01% | 3856 |
|
|
2022
Q1 | $2K | Sell |
451
-311
| -41% | -$1.52K | ﹤0.01% | 3842 |
|
|
2021
Q4 | $5K | Buy |
762
+311
| +69% | +$2.16K | ﹤0.01% | 3652 |
|
|
2021
Q3 | $3K | Hold |
451
| – | – | ﹤0.01% | 3802 |
|
|
2021
Q2 | $6K | Hold |
451
| – | – | ﹤0.01% | 3568 |
|
|
2021
Q1 | $5K | Hold |
451
| – | – | ﹤0.01% | 3499 |
|
|
2020
Q4 | $4K | Buy |
+451
| New | +$3.25K | ﹤0.01% | 3455 |
|
|
2018
Q4 | – | Sell |
-3,435
| Closed | -$21K | – | 3645 |
|
|
2018
Q3 | $21K | Sell |
3,435
-1,565
| -31% | -$7.07K | ﹤0.01% | 2913 |
|
|
2018
Q2 | $32K | Sell |
5,000
-207
| -4% | -$1.47K | ﹤0.01% | 2767 |
|
|
2018
Q1 | $36K | Hold |
5,207
| – | – | ﹤0.01% | 2751 |
|
|
2017
Q4 | $66K | Buy |
5,207
+3,500
| +205% | +$42.7K | ﹤0.01% | 2457 |
|
|
2017
Q3 | $20K | Buy |
1,707
+300
| +21% | +$4.45K | ﹤0.01% | 2899 |
|
|
2017
Q2 | $21K | Buy |
1,407
+1,000
| +246% | +$13.3K | ﹤0.01% | 2863 |
|
|
2017
Q1 | $4K | Hold |
407
| – | – | ﹤0.01% | 3255 |
|
|
2016
Q4 | $4K | Hold |
407
| – | – | ﹤0.01% | 3245 |
|
|
2016
Q3 | $3K | Buy |
+407
| New | +$3.22K | ﹤0.01% | 3277 |
|
|
2016
Q2 | – | Sell |
-276
| Closed | -$2K | – | 3596 |
|
|
2016
Q1 | $2K | Sell |
276
-39
| -12% | -$324 | ﹤0.01% | 3367 |
|
|
2015
Q4 | $3K | Buy |
315
+73
| +30% | +$633 | ﹤0.01% | 3361 |
|
|
2015
Q3 | $2K | Sell |
242
-258
| -52% | -$2.72K | ﹤0.01% | 3432 |
|
|
2015
Q2 | $6K | Hold |
500
| – | – | ﹤0.01% | 3254 |
|
|
2015
Q1 | $5K | Buy |
+500
| New | +$4.68K | ﹤0.01% | 3292 |
|
Other funds holding MDXG
EWM
TI
NCM
PCMI
US Bancorp's MDXG Position: Q2 2026 in Review
US Bancorp opened a new position in MiMedx Group (MDXG) in Q2 2026: 60 shares worth $231. The stake represents ﹤0.01% of the portfolio and ranks #4103 among its holdings. This is a return to the name: US Bancorp previously reported a position in MDXG as recently as Q3 2025.
US Bancorp first reported a position in MDXG in Q1 2015 and has held it in 35 quarters since. The position peaked at $66K in Q4 2017. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.
- US Bancorp held 60 shares of MiMedx Group worth $231 as of Q2 2026.
- MiMedx Group was a new US Bancorp position in Q2 2026.
- MiMedx Group made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4103 holding.
- US Bancorp first reported a position in MiMedx Group in Q1 2015 and has held it in 35 quarters since.
- US Bancorp's MiMedx Group position peaked at $66K in Q4 2017.
- 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.